1. Chitosan Glutamate-Coated Niosomes: A Proposal for Nose-to-Brain Delivery
   Federica Rinaldi et al, 2018, Pharmaceutics CrossRef
2. RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer—a Review
   Gowri Palanissami et al, 2018, HORM CANC CrossRef
3. Pentamidine protects mice from cecal ligation and puncture-induced brain damage via inhibiting S100B/RAGE/NF-κB
   Li Huang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
4. S100 proteins in obesity: liaisons dangereuses
   Francesca Riuzzi et al, 2019, Cell. Mol. Life Sci. CrossRef
5. S100A1 and S100B: Calcium Sensors at the Cross-Roads of Multiple Chondrogenic Pathways
   José Diaz-Romero et al, 2017, J. Cell. Physiol. CrossRef
6. Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wt p53 rescue
   Luisa Seguella et al, 2020, J Cell Mol Med CrossRef
7. Niosomes: A review on niosomal research in the last decade
   Peeyush Bhardwaj et al, 2020, Journal of Drug Delivery Science and Technology CrossRef
8. An aliphatic group-tethered iridium complex as a theranostic agent against malignant melanoma metastasis
   Ke-Jia Wu et al, 2020, ACS Appl. Bio Mater. CrossRef
9. null
   Gopalkrishna Sreejit et al, 2020 CrossRef
10. A transcribed ultraconserved noncoding RNA, Uc.173, is a key molecule for the inhibition of lead-induced neuronal apoptosis
    Aruo Nan et al, 2016, Oncotarget CrossRef
11. Pentamidine inhibit S100A4 - p53 interaction and decreases cell proliferation activity
    Revansiddha H. Katte et al, 2020, Archives of Biochemistry and Biophysics CrossRef
12. Interfering with S100B–effector protein interactions for cancer therapy
    Ke-Jia Wu et al, 2020, Drug Discovery Today CrossRef
13. Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers
    Pak Hin Chow et al, 2020, Cancers CrossRef
14. Amyloid-ß peptides inhibit the expression of AQP4 and glutamate transporter EAAC1 in insulin-treated C6 glioma cells
    Se-Ho Park et al, 2020, Toxicology Reports CrossRef
15. XCHD Inhibits C6 Cell Growth Primarily via the p53/Caspase Pathway
    Huiling Yu et al, 2020, Evidence-Based Complementary and Alternative Medicine CrossRef
16. Simultaneous blocking of the pan‐RAF and S100B pathways as a synergistic therapeutic strategy against malignant melanoma
    Ke‐Jia Wu et al, 2020, J Cell Mol Med CrossRef
17. Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
    Marta Valenza et al, 2021, Biomolecules CrossRef
18. S100P Interacts with p53 while Pentamidine Inhibits This Interaction
    Revansiddha H. Katte et al, 2021, Biomolecules CrossRef
19. Growing role of S100B protein as a putative therapeutic target for neurological- and nonneurological-disorders.
    Maria elisabetta Clementi, 0 CrossRef
20. Successful and Unsuccessful Brain Aging in Pets: Pathophysiological Mechanisms behind Clinical Signs and Potential Benefits from Palmitoylethanolamide Nutritional Intervention
    Caterina Scuderi et al, 2021, Animals CrossRef
21. Preparation of pH-Responsive Vesicular Deferasirox: Evidence from In Silico, In Vitro, and In Vivo Evaluations
    Mahmood Barani et al, 2021, ACS Omega CrossRef
22. Pluronic F127/carfilzomib-based nanomicelles as promising nanocarriers: synthesis, characterization, biological, and in silico evaluations
    Abbas Rahdar et al, 2021, Journal of Molecular Liquids CrossRef
23. null
    Mahmoud Gharbavi et al, 2023 CrossRef
24. null
    Naser-Aldin Lashgari et al, 2024 CrossRef